Threshold Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Threshold Pharmaceuticals has a total of 292 patents globally, out of which 74 have been granted. Of these 292 patents, more than 17% patents are active. The United States of America is where Threshold Pharmaceuticals has filed the maximum number of patents, followed by Europe and Japan. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Threshold Pharmaceuticals. Threshold Pharmaceuticals was founded in 2001. Threshold Pharmaceuticals works on creating medications for the treatment of cancers. It provides Evofosfamide, a prodrug that becomes active when exposed to the severe hypoxia frequently encountered in malignancies. Do read about some of the most popular patents of Threshold Pharmaceuticals which have been covered by us in this article and also you can find Threshold Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Threshold Pharmaceuticals patent portfolio.

How many patents does Threshold Pharmaceuticals have?

Threshold Pharmaceuticals has a total of 292 patents globally. These patents belong to 67 unique patent families. Out of 292 patents, 51 patents are active.

How Many Patents did Threshold Pharmaceuticals File Every Year?

Threshold Pharmaceuticals Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant Threshold Pharmaceuticals Applications Filed Threshold Pharmaceuticals Patents Granted
2023 1 2
2021 1 1
2018 1
2017 2 3
2016 9 11
2015 6 4
2014 8 5
2013 9 10
2012 32 14
2011 18 5

 

How many Threshold Pharmaceuticals patents are Alive/Dead?

Worldwide Patents Threshold Pharmaceuticals Patents Portfolio

How Many Patents did Threshold Pharmaceuticals File in Different Countries?

Threshold Pharmaceuticals Worldwide Patents

Countries in which Threshold Pharmaceuticals Filed Patents

Country Patent
United States Of America 33
Europe 23
Japan 22
Korea (South) 15
Mexico 11
Australia 11
China 11
Canada 10
South Africa 9
India 9
Russia 8
Austria 8
Singapore 8
Spain 6
Brazil 6
Indonesia 6
Norway 6
Germany 5
Hong Kong (S.A.R.) 5
Taiwan 4
Israel 3
New Zealand 3
Denmark 2
Malta 1
Slovenia 1
Albania 1
Estonia 1
Slovakia 1
Serbia 1
Cyprus 1
Poland 1
Croatia 1
Portugal 1

 

Where are Research Centers of Threshold Pharmaceuticals Patents Located?

Research Centers of Threshold Pharmaceuticals Patents

10 Best Threshold Pharmaceuticals Patents

US6979675B2 is the most popular patent in the Threshold Pharmaceuticals portfolio. It has received 123 citations so far from companies like P&G, Oncolytics Biotech, Mars Inc.

Below is the list of 10 most cited patents of Threshold Pharmaceuticals:

Publication Number Citation Count
US6979675B2 123
US20070043057A1 84
US6989140B2 76
WO2016145092A1 68
WO2017087428A1 54
US20070015771A1 50
WO2008083101A1 47
WO2010048330A1 41
US7001888B2 39
WO2008151253A1 39

 

What Percentage of Threshold Pharmaceuticals US Patent Applications Were Granted?

Threshold Pharmaceuticals (Excluding its subsidiaries) has filed 91 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 26 have been granted leading to a grant rate of 52%. Below are the key stats of Threshold Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Threshold Pharmaceuticals?

Law Firm Total Applications Success Rate
Kilpatrick Townsend & Stockton 58 15.79%
Foley & Lardner 17 52.94%
Cooley Llp 11 100.00%
Mark Hopkins 4 100.00%
Randolph T Apple 1 0%

What are Threshold Pharmaceuticals key innovation segments?

What Technologies are Covered by Threshold Pharmaceuticals?

The chart below distributes patents filed by Threshold Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Threshold Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Threshold Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Threshold Pharmaceuticals?

 

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.